Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4651–4700 of 18416
On June 24, 2024, the Board of Directors (the “Board”) of NN, Inc. (the “Company”) announced that Michael C. Felcher, Senior Vice President, Chief Financial Officer, tendered his resignation from the Company, effective as of the close of business on June 24, 2024.
On June 24, 2024, Cohen & Steers, Inc. (the “Company”) announced the appointment of Raja Dakkuri as Executive Vice President and Chief Financial Officer of the Company, effective on such date.
As previously reported by the Company, Mr. Stadler notified the Company on October 17, 2023 of his intention to retire as Chief Financial Officer during 2024, upon the appointment of his successor. Mr. Stadler has agreed to continue with the Company in the position of Executive Vice President to assist with the transition.
Mr. Confer’s title change to President, Chief Executive Officer and Chief Financial Officer was confirmed
the Company announced that David North, the Company’s Chief Financial Officer (the “CFO”) will retire from the Company, and Laurilee Kearnes will be appointed as the Company’s new CFO
the Company announced that David North, the Company’s Chief Financial Officer (the “CFO”) will retire from the Company, and Laurilee Kearnes will be appointed as the Company’s new CFO
On June 18, 2024, Telomir Pharmaceuticals, Inc. (the “ Company ”) and Nathen Fuentes entered into a Confidential Separation and Mutual General Release Agreement (the “ Separation Agreement ”) whereby both the Company and Mr. Fuentes mutually agreed that Mr. Fuentes’ employment as a Chief Financial Officer of the Company would end as of June 18, 2024.
On June 18, 2024, the Board of the Company appointed Michelle Yanez, MBA as the Chief Financial Officer, of the Company.
On June 24, 2024, Akebia Therapeutics, Inc. (the “Company”) announced the appointment of Erik Ostrowski as the Company’s Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer, effective June 24, 2024
On June 21, 2024, Riverview Bancorp, Inc. (“Company”) announced the appointment of Nicole Sherman as President and Chief Executive Officer of the Company and its financial institution subsidiary, Riverview Bank (“Bank”) effective July 1, 2024.
In connection with Mr. Nordhagen’s departure, the Company appointed Amanda Mobley, the Company’s Director of Accounting, to serve as the Company’s Interim Chief Financial Officer, effective June 18, 2024.
On June 21, 2024, Shimmick Corporation (the “Company”) announced the departure of Devin J. Nordhagen, Chief Financial Officer, effective June 18, 2024.
the Company received a notice from Jin-Goon Kim (“Mr. Kim”), who served as the Chief Executive Officer (“CEO”), the interim Chief Financial Officer (“interim CFO”) and the chairman of the board of directors (the “Board”) of the Company, of his decision to resign as the CEO and the interim CFO of the Company, effectively immediately.
Merrick Friedman was appointed as the CFO of the Company
Vikas Desai was appointed as the CEO and a director of the Company
the Board appointed Hiroshi Nishijima, the Company’s Chief Operating Officer, as interim Chief Executive Officer.
On June 20, 2024, Greg Moran, the Company’s Chief Executive Officer, was terminated from his role.
Effective June 17, 2024, Global Gas Corporation (the “Company”) terminated its Chief Executive Officer, William Bennet Nance, Jr., for “Cause,”
On June 21, 2024, Yishay Curelaru resigned as Chief Financial Officer, Treasurer, Secretary of the Company, effective June 21, 2024, due to his continued service in the Israeli army amidst the reported hostilities and conflict in Israel.
On June 21, 2024, the Board of Directors of Ondas Holdings Inc. (the “Company”) appointed Neil Laird, Interim Chief Financial Officer (principal financial and accounting officer), Treasurer and Secretary of the Company, effective June 21, 2024.
the Company entered into a confidential separation agreement and general release with each of and Jeffrey F. Eisenberg, the Company’s former Chief Executive Officer
the Board of Directors of Xenetic Biosciences, Inc. (the “Company”) appointed James F. Parslow, the Company’s Chief Financial Officer, to the position of Interim Chief Executive Officer.
the retirement of Craig D. Gates, President and Chief Executive Officer, effective June 30, 2024.
appointed Michael Steib as President and Chief Executive Officer and as a member of the Board, effective as of August 12, 2024
promoted Sean Byrnes to Executive Vice President, Chief Financial Officer and Principal Accounting Officer of the Company and the Bank effective July 1, 2024.
Mr. Cameron succeeds Christopher D. Bohn, who was appointed to serve as the Company’s Executive Vice President and Chief Operating Officer in February 2024 and continued to serve as the Company’s Chief Financial Officer until the effective date of Mr. Cameron’s appointment.
On June 17, 2024, CF Industries Holdings, Inc. (“CF Industries” or the “Company”) announced that Gregory D. Cameron has been appointed Executive Vice President and Chief Financial Officer (principal financial officer), effective June 17, 2024.
Peter Adamek will be appointed Vice President and Chief Financial Officer of the Company upon Mr. Ottewell’s retirement.
David Ottewell, Vice President and Chief Financial Officer of NOVAGOLD Resources Inc. (the “Company”), has announced his intention to retire effective July 15, 2024.
Patrick Zammit, the Company’s Executive Vice President, Chief Operating Officer, will be appointed President and Chief Executive Officer of the Company
Richard Hume, the Company’s current President and Chief Executive Officer, will retire from the Company.
On June 19, 2024, the Company announced that Thomas DeByle, age 64, became the Company’s Vice President, Chief Financial Officer and Treasurer, effective June 17, 2024.
On June 17, 2024, David S. Smith announced his decision to retire from his positions as Vice President, Chief Financial Officer and Treasurer of AstroNova, Inc. (the “Company”), effective immediately
John Spence as director and Chief Financial Officer
Appointed were Edward K. West as Director and Chief Executive Officer
On June 18, 2024, Charlotte’s Web Holdings, Inc. (the “Company”) announced the appointment of Erika Lind, age 52, as the Company’s Chief Financial Officer effective June 29, 2024.
Jessica Saxton, who provided notice to the Company on June 17, 2024, that she will depart the Company effective June 28, 2024.
On June 15, 2024, the Board of Directors appointed Pablo Castanos, the then-current Executive Vice President, as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.
Effective June 17, 2024, Warren Rehn resigned as President and Chief Executive Officer (Principal Executive Officer) of Golden Minerals Company
Effective immediately, t he Board of Directors of the Company has appointed Raja Bal, the Company’s Chief Accounting Officer, to serve as the acting Chief Financial Officer and principal financial officer.
On June 18, 2024, CoStar Group, Inc. (“CoStar” or the “Company”) announced the appointment of Christian Lown as Chief Financial Officer of the Company, effective July 1, 2024.
Evan Kiefer stepped down from his position of Senior Vice President, Chief Financial Officer, and Treasurer of Black Stone Minerals GP, L.L.C., the Partnership’s general partner (the “General Partner”), on May 28, 2024.
On June 17, 2024, Mr. George Way, the Chief Financial Officer of Dominari Holdings Inc., a Delaware corporation (the “Company”), informed the Company of his decision to voluntarily resign from his position to pursue other professional opportunities.
On June 13 2024, Elijah May, as the Company’s sole director, signed a board resolution, whereby Mr. May resigned from his positions as director, Chief Executive Officer, and President of the Company, effective as of June 13, 2024.
In the same board resolution, Claude Zdanow was appointed as a director of the Company by its Board of Directors, holding the positions of President and Chief Executive Officer.
On June 13, 2024, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), entered into an employment agreement (the “Employment Agreement”) with Mr. Timothy J. Lorber, CPA, 65, pursuant to which Mr. Lorber will serve as the Company’s part-time Chief Financial Officer until September 9, 2024 (the “Transition Period”) and, effective September 10, 2024, Mr. Lorber will assume the role of full-time Chief Financial Officer of the Company.
The Board has subsequently approved the appointment of Mr. Salzman as Chief Executive Officer on a permanent, non-interim basis effective upon the execution of an employment agreement with Mr. Salzman on June 11, 2024.
On June 17, 2024, the board of directors of the Company appointed Jason Bengel, LendingTree, LLC’s Senior Vice President, Financial Planning and Analysis as Chief Financial Officer of the Company effective as of August 9, 2024.
On June 12, 2024, Trent Ziegler informed LendingTree, Inc. (the “Company”) of his intent to resign as Chief Financial Officer of the Company effective as of August 9, 2024.
Mr. Peyovich will succeed Mr. Nielsen as the Company's Chief Executive Officer following the Retirement Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.